 continu infus carboplatin schedul phase pharmacokinet studi phase continu infus carboplatin day week venou access port portabl pump dose rang increment forty-four patient cours median rang world health organ who iii/iv leukopenia thrombocytopenia patient patient cumul platelet depress dose level median glomerular filtrat rate gfr effect renal plasma flow radioisotop clearanc dose equal cours relationship percentag platelet depress gfr toxic patient evalu complet respons partial respons addit patient stabl diseas pharmacokinet analysi total ultrafiltr platinum ufpt atom absorpt spectrophotometri steady-st plasma level ufpt hour level dose steadi state carboplatin dose ufpt plasma level steady-st ufpt gfr twenty-four percent total platinum Pt present ufpt steadi state micrograms/l total bodi clearanc ufpt gfr time mean area curv auc ufpt continu infus mg.min/l total Pt steady-st plasma level total Pt plasma level day day signific relat total Pt serum level day drug dose immunohistochem analysi dna-bound Pt leukocyt linear increas day day day dna-bound Pt durat infus individu patient maximum-toler dose carboplatin day total phase II studi